Akero Therapeutics, Inc. Capital Expenditures
Akero Therapeutics, Inc. reported Capital Expenditures of $148.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-02-25.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2022-02-25
- Akero Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2020-12-31 was $5.00K.
- Akero Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2020 was $148.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|
| 2020-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $148.00K 10-K · filed 2022-02-25 | |
| 2020-09-30 | $143.00K 10-Q · filed 2021-11-12 |